Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Minerva Pediatr ; 61(3): 263-72, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19461570

ABSTRACT

Parenteral nutrition associated liver disease is the most common complication of pediatric short bowel syndrome (SBS). There is emerging evidence that the disease may be reversed with the use of parenteral lipid emulsions derived from fish-oils, which contain significant concentrations of omega-3 fatty acids (w3FA). This paper will review the rationale for the use of parenteral lipid emulsions containing w3FA in SBS and the evidence for their efficacy. Given the promising results and apparent safety of these emulsions, we shall also consider what the current role for PN lipid emulsions containing w3FA in children with SBS should be.


Subject(s)
Fat Emulsions, Intravenous/therapeutic use , Fatty Acids, Omega-3/therapeutic use , Short Bowel Syndrome/drug therapy , Animals , Cholestasis/drug therapy , Evidence-Based Medicine , Fat Emulsions, Intravenous/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Humans , Infant , Parenteral Nutrition/methods , Practice Guidelines as Topic , Short Bowel Syndrome/physiopathology , Treatment Outcome
2.
J Pediatr Gastroenterol Nutr ; 33(5): 543-7, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11740226

ABSTRACT

BACKGROUND: Laparoscopic-assisted ileocolic resection for Crohn disease has been reported as an acceptable alternative to the open procedure in adults. We evaluated our experience with this procedure in the adolescent population. METHODS: All adolescents undergoing ileocolic resection for Crohn disease during a 3-year period were retrospectively reviewed. Intraoperative and early postoperative results were analyzed, comparing those undergoing the laparoscopic-assisted approach with those having open resection. RESULTS: Eleven patients (mean age, 15.6 years) underwent open and 12 patients (mean age, 16.5 years) underwent laparoscopic-assisted resection. None had undergone previous resection. The two groups did not differ with respect to time from diagnosis to surgery, indications for surgery, preoperative medical therapy, operative time, or length of intestine resected. One patient in the laparoscopic-assisted group was converted to an open procedure. There were no intraoperative complications in either group. Although no statistically significant differences were noted for number of days on narcotic, total dosage of narcotic, and time to regular diet, patients undergoing laparoscopic-assisted resection were discharged 2.2 days earlier (5.4 vs. 7.6; P < 0.05). There was one wound infection and one intraabdominal abscess in the open resection group, and a single patient in the laparoscopic-assisted group with postoperative fever and a wound infection. CONCLUSIONS: Laparoscopic-assisted ileocolic resection is a safe alternative to open surgery in adolescent patients with Crohn disease.


Subject(s)
Colon/surgery , Crohn Disease/surgery , Ileum/surgery , Laparoscopy/methods , Adolescent , Anastomosis, Surgical/methods , Anastomosis, Surgical/rehabilitation , Female , Humans , Length of Stay , Male , Parenteral Nutrition, Total , Postoperative Complications , Retrospective Studies , Safety , Surgical Stapling , Surgical Wound Infection
3.
J Am Acad Child Adolesc Psychiatry ; 38(4): 402-9, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10199111

ABSTRACT

OBJECTIVE: To determine whether comorbid anxiety alters response to methylphenidate (MPH) in children with attention-deficit hyperactivity disorder (ADHD). METHOD: Ninety-one children with ADHD were assessed for anxiety. Children were randomly assigned to receive MPH or placebo, titrated to a dose of 0.7 mg/kg, while side effects were minimized. Measures of side effects and behavioral response were obtained from parents and teachers before treatment, after titration to optimal dose, and after 4 months of treatment. These measures, dose of drug, and rate of adherence to assigned medication assignment were compared for nonanxious (ADHD- ANX) and anxious ADHD children (ADHD+ ANX). RESULTS: Rates of adherence to original medication assignment did not differ between the groups. ADHD+ ANX on both MPH and placebo titrated to a lower dose at the end of titration, although the dose of drug did not differ among the groups after 4 months of treatment. No differential response to MPH between ADHD+ ANX and ADHD- ANX was noted at end-titration or at 4 months on any side effect or behavioral measures. CONCLUSIONS: Comorbid anxiety does not appear to influence development of side effects or behavioral response to MPH when dose is titrated as in standard clinical practice.


Subject(s)
Anxiety Disorders/complications , Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/drug therapy , Central Nervous System Stimulants/therapeutic use , Methylphenidate/therapeutic use , Anxiety Disorders/psychology , Attention Deficit Disorder with Hyperactivity/diagnosis , Child , Female , Humans , Male , Psychiatric Status Rating Scales
SELECTION OF CITATIONS
SEARCH DETAIL
...